pargyline has been researched along with Appetite Disorders in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, M | 1 |
| Uchimura, H | 1 |
| Hirano, M | 1 |
| Saito, M | 1 |
| Nakahara, T | 1 |
| Adnitt, PI | 1 |
| Teichmann, G | 1 |
| Thiel, H | 1 |
| Riethling, AK | 1 |
| Völkner, E | 1 |
| Harms, R | 1 |
3 other studies available for pargyline and Appetite Disorders
| Article | Year |
|---|---|
Effects of reserpine and pargyline on glutamate decarboxylase activity in rat hypothalamic nuclei.
Topics: Animals; Body Weight; Brain; Carbon Dioxide; Carboxy-Lyases; Feeding and Eating Disorders; Glutamate | 1976 |
Monoamineoxidase inhibition and insulin sensitivity.
Topics: Animals; Body Weight; Drug Synergism; Feeding and Eating Disorders; Growth Hormone; Humans; Hydrazin | 1968 |
[Gastrointestinal side effects of medicamentous antihypertensive therapy].
Topics: Antihypertensive Agents; Constipation; Diarrhea; Feeding and Eating Disorders; Gastrointestinal Dise | 1971 |